Researchers from the University of North Carolina-Chapel Hill found the health risks of newborns born to women with breast cancer varied depending on the mother’s type of cancer.

Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., one of the world's leading companies in the diagnostic imaging business, announced today that the labeling of its contrast agent MultiHance® has obtained FDA approval for an extension to include MRI of the CNS in pediatric patients younger than 2 years of age (including term neonates), to visualize lesions with abnormal blood-brain barrier or abnormal vascularity of the brain, spine, and associated tissues.

Disruption of the internal body clock is commonly associated in people with Alzheimer’s Disease (AD) and may lead to further development of the disorder. New research suggests circadian rhythm abnormalities occur earlier in people who don’t have AD, but whose brain scans may show early risk of developing the disease.

Brain imaging advances can determine a greater number of stroke victims who can receive therapy later than previously thought, according to a new study published in The New England Journal of Medicine.

A group of Oxford researchers repurposed MR technology to image the skull, rather than just the brain, in a study designed to rigorously test the dated pseudoscience of phrenology.

Training using transesophageal echocardiography (TEE) simulators typically relies on grainy drawings of patients in black and white. But a new version, developed by a team from the University of Washington led by Florence Sheehan, MD, can display 3D images of a hypothetical patient, allowing users to look for blood clots and other abnormalities.

A Children’s National Health System team has found velocity-selective arterial spin labeling (VSASL), an advanced MRI technology, can detect early signs of global placental perfusion in pregnancies complicated by fetal congenital heart disease (CHD).

Researchers, investigating how community practices are following breast cancer screening guidelines, found that high-risk individuals, especially those with a family history of the disease, were not receiving additional MRI scans to help in early detection.